Back Source: > 28 November 2009 (E-Business) InterMune, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile--Aarkstore Enterprise New report "InterMune, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" available through Aarkstore.com  InterMune, Inc. (InterMune) is a biopharmaceutical company engaged in the development and marketing of innovative therapies in areas of pulmonology and hepatology. The company is developing a pipeline of pulmonology and hepatology products for treating idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. Its pulmonology products consist of a Phase 3 program, CAPACITY for treating patients with IPF and a research program on small molecules for pulmonary diseases. Its hepatology product is the HCV protease inhibitor compound ITMN-191 and a research program which evaluates new targets in hepatology. The company is headquartered in California, United States InterMune, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals. Scope - Provides key company information for business intelligence needs - Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement. For more information please visit : http://www.aarkstore.com/reports/InterMune-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-19989.html  Visit